Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients

NCT02459288 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome
Chronic Kidney Disease
End-Stage Renal Disease

Interventions

DRUG: Clopidogrel first
DRUG: Ticagrelor first

Sponsor

Ping-Yen Liu